Establishment of novel testing methods for medical devices (Q3307600): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item: import item from Germany) |
||||||
| Property / EU contribution | |||||||
40,000.0 Euro
| |||||||
| Property / EU contribution: 40,000.0 Euro / rank | |||||||
Normal rank | |||||||
| Property / co-financing rate | |||||||
40.0 percent
| |||||||
| Property / co-financing rate: 40.0 percent / rank | |||||||
Normal rank | |||||||
Revision as of 13:04, 27 October 2021
Project Q3307600 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Establishment of novel testing methods for medical devices |
Project Q3307600 in Germany |
Statements
40,000.0 Euro
0 references
100,000.0 Euro
0 references
40.0 percent
0 references
24 March 2020
0 references
23 March 2022
0 references
Aventra GmbH
0 references
52°16'19.06"N, 8°2'51.50"E
0 references
Im vorliegenden Projekt entwickelt AVENTRA innovative Prüfverfahren für Medizinprodukte nach den Vorgaben der neuen Medizinproduktverordnung von 2017. (German)
0 references
In this project, Aventra develops innovative test procedures for medical devices in accordance with the requirements of the new Medical Devices Ordinance of 2017. (English)
24 October 2021
0 references
Osnabrück, Stadt
0 references
Identifiers
DE_TEMPORARY_10385
0 references